NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT01670084 2015-10-30Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous LeukemiaMayo ClinicPhase 2 Withdrawn
NCT00005641 2012-12-11Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow TransplantationH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Terminated
NCT00003331 2011-03-28Combination Chemotherapy in Treating Patients With Advanced CancerNYU Langone HealthPhase 1 Completed30 enrolled